209 related articles for article (PubMed ID: 11220664)
1. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
Hecht SS
IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
[TBL] [Abstract][Full Text] [Related]
2. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
3. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer.
Nair U; Bartsch H
IARC Sci Publ; 2001; 154():271-90. PubMed ID: 11220667
[TBL] [Abstract][Full Text] [Related]
4. Biological relevance of adduct detection to the chemoprevention of cancer.
Sharma RA; Farmer PB
Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Kensler TW; Groopman JD
J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
[TBL] [Abstract][Full Text] [Related]
6. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
8. Methods and strategies in lung cancer control.
Castonguay A
Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994
[TBL] [Abstract][Full Text] [Related]
9. Application of molecular epidemiology to lung cancer chemoprevention.
Mooney LA; Perera FP
J Cell Biochem Suppl; 1996; 25():63-8. PubMed ID: 9027600
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and surrogacy: relevance to chemoprevention.
Kensler TW; Davidson NE; Groopman JD; Muñoz A
IARC Sci Publ; 2001; 154():27-47. PubMed ID: 11220666
[TBL] [Abstract][Full Text] [Related]
11. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
De Flora S; Balansky R; Scatolini L; Di Marco C; Gasparini L; Orlando M; Izzotti A
IARC Sci Publ; 1996; (139):291-301. PubMed ID: 8923039
[TBL] [Abstract][Full Text] [Related]
12. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
13. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer chemoprevention: an integrated approach.
Lippman SM; Spitz MR
J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
[TBL] [Abstract][Full Text] [Related]
15. Benzo[A]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue.
Walle T; Walle UK; Sedmera D; Klausner M
Drug Metab Dispos; 2006 Mar; 34(3):346-50. PubMed ID: 16381670
[TBL] [Abstract][Full Text] [Related]
16. Determination of biomarkers for intermediate end points in chemoprevention trials.
Lee JS; Lippman SM; Hong WK; Ro JY; Kim SY; Lotan R; Hittelman WN
Cancer Res; 1992 May; 52(9 Suppl):2707s-2710s. PubMed ID: 1348662
[TBL] [Abstract][Full Text] [Related]
17. Early detection and chemoprevention of lung cancer.
Shaipanich T; McWilliams A; Lam S
Respirology; 2006 Jul; 11(4):366-72. PubMed ID: 16771906
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers.
Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R
Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729
[TBL] [Abstract][Full Text] [Related]
19. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
Sanner T; Dybing E
Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
[TBL] [Abstract][Full Text] [Related]
20. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
